Medtronic Infuse Litigation

  • Issue: Improper off-label use
  • Result: Confidential settlement
  • Year: 2014

Lieff Cabraser represented patients who suffered serious injuries from the off-label use of the Infuse bone graft, manufactured by Medtronic Inc.

The FDA approved Infuse for only one type of spine surgery, the anterior lumbar fusion. Many patients, however, received an off-label use of Infuse and were never informed of the off-label nature of the surgery. Serious complications associated with Infuse included uncontrolled bone growth and chronic pain from nerve injuries.

In 2014, the litigation was settled on confidential terms.


By Wendy Fleishman

Injury Law FAQ: ANSWERS TO YOUR QUESTIONS

PERSONAL INJURY TESTIMONIALS

"You were responsive to my questions and concerns at all times. The quality of representation was excellent."

Jill in Indiana
Client in dangerous prescription drug case View More Testimonials